Molecular taxonomy of MDS/CMML patients influences responses to hypomethylating agents and clinical outcomes. Molina A, Khanna V, Jensen A, Stehr H, et al. Leuk Res 2025;156:107736.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Molina A, Khanna V, Jensen A, Stehr H, et al. Molecular taxonomy of MDS/CMML patients influences responses to hypomethylating agents and clinical outcomes. Leuk Res 2025;156:107736.
PMID: 40684748